Yutao Liu, Yongchang Zhang, Liang Zeng, Yan Yu, Bo Pan, Yongzhong Luo, Hua Zhong, Rong Qiao, Xiangjiao Meng, Dan Yang, Jin Cao, Guixiang Weng, Shanshan Gu, Tianyu Ren, Bo Yang, Jianmin Fang, Yuankai Shi. "RC108 in combination with furmonertinib in patients with locally advanced or metastatic EGFR-mutated non-small-cell lung cancer (NSCLC) with MET overexpression: Results from a phase Ib/II trial.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.8592